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Mice carrying heterozygous mutations in the Sox10 gene display aganglionosis of the colon and represent a model for human
Hirschsprung disease. Here, we show that the closely related Sox8 functions as a modifier gene for Sox10-dependent enteric nervous system
defects as it increases both penetrance and severity of the defect in Sox10 heterozygous mice despite having no detectable influence on
enteric nervous system development on its own. Sox8 exhibits an expression pattern very similar to Sox10 with occurrence in vagal and
enteric neural crest cells and later confinement to enteric glia. Loss of Sox8 alleles in Sox10 heterozygous mice impaired colonization of the
gut by enteric neural crest cells already at early times. Whereas proliferation, apoptosis, and neuronal differentiation were normal for enteric
neural crest cells in the gut of mutant mice, apoptosis was dramatically increased in vagal neural crest cells outside the gut. The defects in
enteric nervous system development of mice with Sox10 and Sox8 mutations are therefore likely caused by a reduction of the pool of
undifferentiated vagal neural crest cells. Our study suggests that Sox8 and Sox10 are jointly required for the maintenance of these vagal
neural crest stem cells.
D 2004 Elsevier Inc. All rights reserved.
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The neural crest forms a migratory and multipotential
cell population in the early vertebrate embryo which gives
rise or contributes to many different organ systems (Le
Douarin and Kalchheim, 1999). Accordingly, developmen-
tal defects of the neural crest are diverse. With a frequency
of approximately 1 in 4500 newborns, Hirschsprung disease
(HSCR or aganglionic megacolon, MIM 142623) is one of
the more common of these neurocristopathies (Chakravarti,
2001). Hirschsprung disease is an intestinal disorder in
which the enteric nervous system (ENS) fails to innervate
the distal part of the colon over variable distances leading to
intestinal obstruction and chronic constipation in affected
individuals. Primarily affected are cells derived from the0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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the level of the esophagus, migrate as enteric neural crest
cells in a caudal direction through the entire length of the
gut and form the ENS (Newgreen and Young, 2002).
Mutations in several genes lead to Hirschsprung disease.
Some of the identified mutations are sporadic, others are
inherited. The genetics of Hirschsprung disease are complex
with monogenic and oligogenic cases, syndromic and non-
syndromic forms as well as dominant and recessive
inheritance patterns (Chakravarti, 2001). The gene for the
c-RET receptor tyrosine kinase is most frequently affected
(Edery et al., 1994). Mutations in this gene alone or in
combination with alterations in two other loci account for
approximately half of all congenital Hirschsprung cases
(Gabriel et al., 2002). In addition to its complex genetics,
Hirschsprung disease also exhibits strong phenotypic
variability pointing to considerable influences from environ-
ment and modifying genetic factors.
Additional genes in which mutations have been identi-
fied that lead or contribute to Hirschsprung disease are other277 (2005) 155–169
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paracrine glial cell line-derived neurotrophic factor (GDNF)
(Angrist et al., 1996; Salomon et al., 1996). Analogously,
mutations in both the gene for endothelin-3 (EDN3) and the
gene for endothelin receptor B (EDNRB) can cause
Hirschsprung disease (Edery et al., 1996; Puffenberger et
al., 1994) showing that the genetic defect can be autono-
mous to the cells of the ENS (as is the case for receptor
mutations) or mediated by the gut environment and thus
non-autonomous (as for ligand mutations).
Hirschsprung disease can also be caused by alterations in
genes whose products directly regulate the pattern of gene
expression as transcription factors or co-factors in cells of
the ENS or their precursors. Examples of such genes are
ZFHX1B encoding the Smad-interacting protein 1 (SIP1),
and SOX10 encoding a high-mobility-group-box containing
transcription factor of the Sox family (Cacheux et al., 2001;
Pingault et al., 1998; Wakamatsu et al., 2001). SOX10
alterations in Hirschsprung patients are usually heterozy-
gous mutations that either lead to truncated, non-functional
versions of the protein or to a complete loss of expression
from the affected allele (Kuhlbrodt et al., 1998b). This
haploinsufficiency points to sensitivity of the ENS to
SOX10 dosage.
Within the Sox family of transcription factors, SOX10
forms a separate group with two closely related proteins,
SOX9 and SOX8 (Bowles et al., 2000; Wegner, 1999).
Whereas mutations of SOX9 lead to autosomal sex reversal
and the severe skeletal malformation syndrome Campomelic
dysplasia (Foster et al., 1994; Wagner et al., 1994), no
disease has so far been associated with SOX8. Analysis in
mice revealed that Sox8 is co-expressed with either Sox9 or
Sox10 in many tissues, including the male gonad, muscle,
the central nervous system, early neural crest cells, and
chondrocytes (Chaboissier et al., 2004; Cheung and Briscoe,
2003; Schepers et al., 2003; Schmidt et al., 2003; Sock et
al., 2001; Stolt et al., 2004), arguing for functional
redundancy among these three Sox proteins. This functional
redundancy might also explain the lack of a severe
phenotype in Sox8-deficient mice (Sock et al., 2001).
Spontaneous and targeted mutations have been identified
or generated for many mouse orthologs of human Hirsch-
sprung disease genes (for review, see Gershon, 1999). Most
of the corresponding mouse mutants exhibit defects in the
development of the ENS, and impressively confirm the link
between defects in these genes and Hirschsprung disease.
Nevertheless, the exact phenotype often differs between
humans and the mouse model, usually due to different gene
dosage requirements in both species. In mice with hetero-
zygous c-Ret mutations, for instance, there are no apparent
changes in the ENS (Schuchardt et al., 1994), despite the
fact that heterozygous c-RET mutations are the most
common cause of Hirschsprung disease in humans (Gabriel
et al., 2002).
Mice with genetic alterations of the Sox10 gene faithfully
reproduce the Hirschsprung phenotype as well as theincomplete penetrance and phenotypic variability (Herbarth
et al., 1998; Paratore et al., 2002; Southard-Smith et al.,
1998). The penetrance varies between different genetic
backgrounds; C57Bl/6J mice, for instance, are affected at a
higher rate than C3HeB/FeJ mice (Southard-Smith et al.,
1999). In diseased mice, there is an enormous phenotypic
variation with aganglionosis affecting different lengths of
the colon. Both phenotypic variability and incomplete
penetrance point to the existence of so far poorly charac-
terized genetic modifiers (Southard-Smith et al., 1999).
Here, we have exploited the availability of mice with
targeted mutation in the Sox10 and Sox8 genes to show that
Sox8 functions as such a modifier. We also obtained evidence
that both genes influence survival of early neural crest cells.
As a consequence, ENS defects in mice with Sox8 and Sox10
deletions are primarily due to strongly increased rates of
apoptosis in vagal neural crest cells. Thus, developmental
defects that ultimately lead to Hirschsprung disease may
occur in the neural crest prior to gut colonization.Materials and methods
Animal husbandry, genotyping, BrdU labeling, and tissue
preparation
Mice with a Sox8lacZ allele (Sock et al., 2001) were kept
as heterozygotes or homozygotes in the presence or absence
of a Sox10lacZ allele on a mixed C57Bl/6J:C3HeB/FeJ
background (Britsch et al., 2001). For the generation of
embryos and pups during this study, Sox8+/lacZ mice were
crossed with Sox8+/lacZ, Sox10+/lacZ double heterozygotes.
Genotyping was performed by PCR as described (Britsch et
al., 2001; Sock et al., 2001). For BrdU labeling, pregnant
mice were injected with 100 Ag BrdU (Sigma) per gram
body weight 24 h before embryo preparation (Stolt et al.,
2003). Embryos (from 9.5 to 16.5 dpc) were obtained from
staged pregnancies. After fixation in paraformaldehyde, 20
Am sections of genotyped, age-matched mouse embryos
were generated on a cryotome, and used for immunohis-
tochemistry. Alternatively, guts dissected from embryos
were used for whole-mount immunohistochemistry or
whole-mount X-Gal staining.
Immunohistochemistry and X-Gal staining
For immunohistochemistry, the following primary anti-
bodies were used in various combinations: anti-Sox10
guinea pig antiserum (1:2000 dilution), anti-NOS rabbit
antiserum (1:500 dilution, Alexis Biochemicals), anti-
PGP9.5 rabbit antiserum (1:400 dilution, Biotrend), anti-
B-FABP rabbit antiserum, (1:10,000 dilution, gift of C.
Birchmeier and T. Mqller, MDC, Berlin), anti-S100h rabbit
antiserum (1:500 dilution, Dako), anti-h-galactosidase
rabbit antiserum (1:500 dilution, ICN) or anti-h-galactosi-
dase goat antiserum (1:500 dilution, Biotrend). The guinea
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bacterially expressed protein consisting of amino acids 181–
233 and 308–400 of rat Sox10 (Stolt et al., 2003) and did
not cross-react with the related Sox8 or Sox9. Secondary
antibodies conjugated to Cy2 and Cy3 immunofluorescent
dyes (Dianova) were used for detection. TUNEL assays
were performed using the ApopTag Red In Situ Apoptosis
Detection Kit (Q Biogene). Incorporated BrdU was detected
on tissue sections using an Alexa-488 coupled mouse
monoclonal antibody directed against BrdU (Molecular
Probes) at a 1:20 dilution. X-gal stainings followed standard
procedures. Samples were analyzed and documented using
either a Leica TCS SL confocal microscope or a Leica
inverted microscope (DMIRB) equipped with a cooled
MicroMax CCD camera (Princeton Instruments, Stanford).
Preparation of acutely dissociated gut cell cultures and gut
homogenates
Cell culture preparations of dissociated gut regions were
done as described (Paratore et al., 2002). Briefly, dissected
gut regions from embryos at 12.5 and 14.5 dpc were
digested in 1 mg/ml collagenase type I (Worthington
Biochemical, NJ, USA) in PBS for 30 min at 378C. For
guts obtained from 16.5-dpc-old embryos, 0.01% trypsin
(Invitrogen) was additionally added. After addition of fetal
calf serum (FCS) to a final concentration of 1%, cells were
collected by centrifugation, triturated, and plated at suitable
densities in duplicate wells onto fibronectin coated cover
slips in Dulbecco’s modified Eagle’s medium containing
10% FCS. After 3 h, most cells were adherent and were
fixed in paraformaldehyde. No differential cell adherence
was observed in gut preparations from different genotypes.
Cells on cover slips were immunostained, counterstained by
DAPI, photographed and scored for marker expression. At
least four cover slips from two different embryos were
analyzed for each genotype and developmental stage.
Homogenates were prepared from freshly dissected guts
and from the post-otic region of 9.5 dpc-old embryos that
harbors the vagal neural crest using a Polytron PT1200
homogenizer. Faeces were removed from postnatal guts
through repeated rinsing prior to homogenization. After
normalization of protein amounts in the homogenates, h-
galactosidase activities were determined using a chemilu-
minescent detection kit (Roche Biochemicals).Results
Sox8 functions as a modifier gene of Sox10 in the ENS
In the past, we have generated mice in which the
complete open reading frame of the Sox8 gene and the
Sox10 gene were each replaced by a lacZ marker (Britsch
et al., 2001; Sock et al., 2001). Sox10-deficient mice died
during embryogenesis or at birth, and completely lackedthe ENS. Sox10+/lacZ mice, on the other hand, were born
at normal Mendelian ratios. However, approximately 20%
of these mice developed a megacolon and died during the
first 3 postnatal weeks. Sox8-deficient mice were viable,
fertile, and without any gross phenotypical abnormalities
apart from a reduced body weight. When intercrossing
Sox8lacZ/lacZ mice with Sox10+/lacZ mice (Fig. 1A), we
noticed a high early postnatal mortality affecting 33% of
the progeny. Of the remaining animals, 76% were
heterozygous for Sox8 and 24% were heterozygous for
both Sox8 and Sox10. As a different set of experiments
revealed equal numbers of both genotypes at birth (data
not shown), double heterozygous animals were lost at
significant rates postnatally.
Whether underrepresentation of double heterozygous
mice was solely due to the previously described occurrence
of a megacolon phenotype in a fraction of Sox10+/lacZ mice
(Britsch et al., 2001) was analyzed in intercrosses between
Sox8+/lacZ mice with Sox10+/lacZ mice (Fig. 1B). Again, we
observed an increased postnatal mortality of 19%. All
animals that were genotyped post-mortem were heterozy-
gous for the Sox10lacZ allele and of variable Sox8 genotype.
The obtained genotype distribution differed in a statistically
significant manner from expected Mendelian ratios. Of the
four genotypes which should all appear at equal ratios,
Sox10 heterozygous mice were present in 20% less than
expected numbers at the time of genotyping. Sox10
heterozygous pups mainly died during the 3rd postnatal
week concomitant with the dietary changes during weaning.
Postmortem analysis confirmed the presence of a megacolon
in all analyzed Sox10+/lacZ mice (compare Figs. 1C and D).
The affected segment, which in the absence of innervation
remained contracted and failed to transport the gut content,
seldomly reached beyond the colon (Fig. 1D). As a
consequence, faeces accumulated in front of the stenotic
segment and grossly distended the adjacent, normally
innervated gut segment, leading to the so-called megacolon.
In contrast, double heterozygous littermates were lost at a
much higher, statistically significant rate. Seventy-seven
percent did not survive the first 3 postnatal weeks (Fig. 1B).
Of these, the majority was already lost during the first 2
postnatal weeks. Although phenotypes varied substantially
between affected double heterozygous mice, the aganglio-
notic segment often extended beyond the caecum for
various lengths into the small intestine (Fig. 1E). Thus, a
heterozygous loss of Sox8 by itself is phenotypically
inapparent, but leads to a dramatic aggravation of the
ENS defect associated with a heterozygous loss of Sox10,
both with regards to increased frequency and increased
severity.
Sox10 and Sox8 exhibit an overlapping expression in the
ENS
To analyze the basis of this phenomenon, we first
compared expression patterns of both Sox proteins in the
Fig. 1. Genotype distribution and phenotypic analyses of mice with combined Sox8 and Sox10 deletions. (A, B) Numbers of 3-week-old mice from various
crossings sorted according to their genotype as indicated below the bars. In (A), Sox10+/lacZ mice were crossed with Sox8lacZ/lacZ mice. Of 362 newborns, 243
survived until weaning including 186 Sox8+/lacZ and 57 Sox8+/lacZ, Sox10+/lacZ mice. In (B), Sox10+/lacZ mice were crossed with Sox8+/lacZ mice. Of 160
newborns, 130 survived until weaning including 50 wildtype, 39 Sox8+/lacZ, 32 Sox10+/lacZ and 9 Sox8+/lacZ, Sox10+/lacZ mice. Open bars, expected numbers;
filled bars, obtained numbers. (C, D, E) Whole-mount preparations of gastrointestinal tracts from wildtype (C), Sox10+/lacZ (D), and Sox8+/lacZ, Sox10+/lacZ (E)
mice. Guts in (C) and (D) were prepared from age-matched animals at postnatal day 18. Preparations for (E) was performed at postnatal day 12 because of
earlier lethality. The arrow indicates the transition from stenotic to dilated gut segment. The stenotic region is aganglionotic and cannot perform peristaltic
movements so that faeces accumulate in the gut region preceding the stenotic segment. The dilated segment, in contrast, has a morphologically normal enteric
nervous system. st, stomach; ce, caecum.
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occur in undifferentiated enteric neural crest cells where it is
down-regulated upon neuronal specification (Paratore et al.,
2002; Young et al., 2003). In contrast, Sox10 remains
present in those enteric crest-derived cells acquiring a glial
fate, and therefore becomes restricted to enteric glia as ENS
development proceeds. We were able to reproduce these
findings in two set-ups: (i) directly with antibodies against
Sox10 on wildtype gut tissue (Figs. 2A–E) and (ii)
indirectly with antibodies against h-galactosidase on
Sox10+/lacZ tissue (Figs. 2F–J). The latter approach was
made possible because the lacZ marker that had been
inserted into the Sox10 null allele faithfully recapitulated
Sox10 expression (Britsch et al., 2001; Stolt et al., 2002). At
12.5 days post-coitum (dpc), both antibodies labeled
PGP9.5-negative enteric neural crest cells (Figs. 2A, F).
PGP9.5 is a ubiquitin hydrolase present in all neuronal
precursors and differentiated neurons (Young and New-
green, 2001). While Sox10/h-galactosidase- and PGP9.5-positive cells remained separate populations at later phases
of ENS development (Figs. 2B, C, G, H), a steadily
increasing fraction of Sox10/h-galactosidase-positive cells
were co-stained with antibodies against the glial marker
S100h (Figs. 2D, E, I, J).
Antibodies against h-galactosidase could also be used to
follow Sox8 expression in the developing ENS. Again, this
was made possible because of the lacZ marker insertion into
the Sox8 null allele (Sock et al., 2001). In essence, the Sox8-
specific h-galactosidase expression in the gut of Sox8+/lacZ
embryos closely resembled the Sox10-specific h-galactosi-
dase pattern in the gut of Sox10+/lacZ embryos at all stages
analyzed (compare Figs. 2K–O with Figs. 2F–J) indicating
that Sox8 is also expressed in pluripotent enteric neural crest
cells and enteric glia, but not in neuronal derivatives of the
enteric neural crest.
To directly compare Sox10 and Sox8 expression in the
developing ENS, we performed co-immunohistochemistry
with antibodies against Sox10 and h-galactosidase on
Fig. 2. Cell type-restricted expression of Sox10 and Sox8 in the embryonic ENS. Whole-mount immunohistochemistry was performed on guts from wildtype
(A–E), Sox10+/lacZ (F–J) and Sox8+/lacZ (K–O) embryos at 12.5 dpc (A, F, K), 14.5 dpc (B, G, L, D, I, N) and 16.5 dpc (C, H, M, E, J, O) using antibodies
against Sox10 or h-galactosidase (red) in combination with cell-type-specific antibodies including PGP9.5 (A–C, F–H, K–M), and S100h (D, E, I, J, N, O)
(green). Magnifications (shown as insets in A–C) prove that Sox10-positive nuclei are separated from PGP9.5-positive cells by unstained cytoplasm. Pictures
were taken from the midgut region using a Leica TCS SL confocal microscope.
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labeled nuclei contained Sox8-specific h-galactosidase in
their cytoplasm both at 12.5 dpc and at 14.5 dpc (Figs. 3A,
B). For quantification, co-immunohistochemistry was also
performed on acutely dissociated gut tissues of Sox8+/lacZembryos (Fig. 3C). At 12.5 dpc, cells from stomach and
midgut were separately quantified. At 14.5 dpc, quantifi-
cation was performed on midgut and hindgut. In all cases,
expression of both markers was intimately linked. Ninety-
four percent to 98% of the Sox10-positive cells were
Fig. 3. Comparison of Sox10 and Sox8 expression in the embryonic ENS.
(A, B) Whole-mount immunohistochemistry was performed on guts from
Sox8+/lacZ embryos at 12.5 dpc (A) and 14.5 dpc (B) using antibodies
against Sox10 (red) and h-galactosidase (green). Pictures were taken from
the midgut region using a Leica TCS SL confocal microscope. (C) The
fraction of Sox10-positive cells co-labeled by Sox8-specific h-galactosidase
were determined in acutely dissociated gut regions from Sox8+/lacZ embryos
at 12.5 and 14.5 dpc. On average, approximately 3000 cells in four separate
cultures from two different embryos were counted. st, stomach; mg, midgut;
hg, hindgut. (D) Quantification of h-galactosidase activities in Sox10+/lacZ
(filled bars) and Sox8+/lacZ (open bars) vagal regions (9.5 dpc) and
intestines (12.5, 14.5, 16.5, and 18.5 dpc) as well as in the adult colon.
Activities are presented as relative light units  103 per microgram gut
extract.
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similarly good correlation was also obtained for the reverse
setup (data not shown). These analyses confirm that Sox8
and Sox10 are co-expressed during development of the
ENS both in enteric neural crest cells and in forming
enteric glia.
To compare expression levels for both Sox proteins, we
quantified h-galactosidase activity in gut homogenates of
Sox8+/lacZ and Sox10+/lacZ mice at various times of develop-
ment. As the same lacZ reporter was inserted in similar
manner into both Sox8 and Sox10 loci (Britsch et al., 2001;
Sock et al., 2001; Stolt et al., 2002, 2004), h-galactosidase
activity should yield an approximate measure for the relative
expression levels of both genes. From 12.5 through 18.5
dpc, h-galactosidase activities were comparable for Sox8
and Sox10 and similarly decreased during late embryo-
genesis (Fig. 3D). In contrast, h-galactosidase activities
differed significantly for both Sox genes in the early vagal
crest and in the adult gut. At 9.5 dpc, h-galactosidase was
expressed at 3-fold higher levels from the Sox10 locus than
from the Sox8 locus in the post-otic region of the embryo
that contained the vagal crest. In the adult, h-galactosidaseactivity was reduced to levels barely above background both
in the colon and small intestine of Sox8+/lacZ mice (Fig. 3D
and data not shown) indicating that Sox8 might be no longer
expressed in the adult gut. This agrees with our previous
failure to detect Sox8 expression in the adult gut by RT PCR
analysis (Sock et al., 2001). In contrast, h-galactosidase
activity was easily detected in Sox10+/lacZ mice because of
the continued expression of Sox10 in enteric glia (Young et
al., 2003).
ENS development is altered in mice with combined Sox8
and Sox10 mutations
As both Sox8- and Sox10-specific h-galactosidase was
expressed in enteric neural crest cells, we used this marker
for analysis of gut colonization and ENS development in
mice with mutant Sox8 and Sox10 alleles. As evident from
immunohistochemistry with Sox10 and PGP9.5 antibodies,
ENS development in Sox8+/lacZ and in Sox8lacZ/lacZ mice
was identical to the wildtype at all times (data not shown),
consistent with the fact that we never observed a megacolon
in mice of these genotypes. In wildtype mice and littermates
with Sox8 deletions, enteric neural crest cells had colonized
most regions of the gut at 12.5 dpc with the migratory
wavefront just past the caecum (Figs. 4A, B). Similar results
were generally obtained for guts of Sox10+/lacZ embryos
(Figs. 4D, E), indicating normal ENS development in most
Sox10 heterozygous embryos. However, a minor fraction of
Sox10+/lacZ embryos displayed a retarded colonization with
enteric neural crest cells being stalled before the caecum
(data not shown). Thus, variability of the gut phenotype in
Sox10 heterozygous animals is already evident at this early
stage of development.
When Sox10 heterozygous animals were analyzed that
had additionally lost one or two Sox8 alleles, colonization of
the gut was strongly delayed in most cases. In general, the
wavefront of migrating enteric neural crest cells appeared
least advanced in Sox8lacZ/lacZ, Sox10+/lacZ embryos, with
most midgut regions still free of enteric neural crest cells
(Figs. 4J, K). In many Sox8+/lacZ, Sox10+/lacZ embryos,
migratory delays were intermediary between those
of Sox8lacZ/lacZ, Sox10+/lacZ embryos and the affected
Sox10+/lacZ embryos (Figs. 4G, H). However, there was a
significant overlap between phenotypes of Sox8+/lacZ,
Sox10+/lacZ embryos and Sox8lacZ/lacZ, Sox10+/lacZ embryos.
Gut colonization in a severely affected Sox8+/lacZ, Sox10+/lacZ
embryo could on occasion be indistinguishable from that in
a weakly affected Sox8lacZ/lacZ, Sox10+/lacZ embryo. It
should also be noted that ENS development appeared
normal in a few Sox8+/lacZ, Sox10+/lacZ embryos in agree-
ment with the fact that 23% of these animals do not develop
a megacolon postnatally (Figs. 1A, B).
When neuronal markers such as PGP9.5 and NOS were
used for the analysis instead of the enteric neural crest
marker h-galactosidase, similar results were obtained, as
neuronal commitment and differentiation already occur
Fig. 4. ENS development in mice with mutant Sox8 and Sox10 alleles at 12.5 dpc. (A–L) Whole-mount immunohistochemistry was performed on guts from
Sox8+/lacZ (A–C), Sox10+/lacZ (D–F), Sox8+/lacZ, Sox10+/lacZ (G–I), and Sox8lacZ/lacZ, Sox10+/lacZ (J–L) embryos using antibodies against h-galactosidase (A, B,
D, E, G, H, J, K) or the neuronal markers PGP9.5 and NOS (C, F, I, L). (B, E, H, K), magnifications of the respective boxed areas in (A, D, G, J). (M, N)
Fraction of Sox10-positive cells in cultures of acutely dissociated stomach (M) and midgut (N). On average, approximately 3500 cells in four separate cultures
from two different embryos were counted for each genotype. Data are presented as mean F SEM. Differences to the wildtype were statistically significant for
Sox8+/lacZ, Sox10+/lacZ and Sox8lacZ/lacZ, Sox10+/lacZ embryos in (N) as determined by the Student’s t test (P V 0.001). Note that gut colonization was retarded
more strongly in the Sox8+/lacZ, Sox10+/lacZ embryos shown in (N) than in the one shown in (G).
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crest cells (Conner et al., 2003). Interestingly, cells of
neuronal identity could be detected in comparable distances
from the wavefront of migrating enteric neural crest cells in
all genotypes thus arguing that there is no genotype-specific
delay in neurogenesis (Figs. 4C, F, I, L).The total number of enteric neural crest cells was also
quantified in cultures from acutely dissociated gut regions
at 12.5 dpc using antibodies directed against Sox10 (Figs.
4M, N). In the stomach, these analyses failed to detect
significant differences in the number of enteric neural crest
cells between genotypes (Fig. 4M, and data not shown).
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midgut, significant reductions to 13–17% of wildtype
numbers became obvious for the analyzed Sox8+/lacZ,
Sox10+/lacZ and Sox8lacZ/lacZ, Sox10+/lacZ embryos (Fig. 4N).
At 14.5 dpc, enteric neural crest cells had reached the
terminal end of the hindgut in both wildtype embryos and
embryos with Sox8 deletions (Figs. 5A–C). This was also
the case for most Sox10+/lacZ embryos (Figs. 5D–F).
However, in some Sox10 heterozygous embryos, coloniza-
tion of the gut by enteric neural crest cells was clearly
disturbed with the distal segment of the hindgut still devoid
of enteric neural crest cells (Figs. 5G–I). The vast majority
of embryos with additional deletions of one or two Sox8
alleles showed a much stronger retardation. In some
embryos of these genotypes, the wavefront of migrating
enteric neural crest cells was found shortly before or behind
the caecum at 14.5 dpc (Figs. 5J–L). In others, the midgut
region had still received hardly any enteric neural crest cells
(Figs. 5M–O). As already observed at 12.5 dpc, the gut
phenotypes of Sox8+/lacZ, Sox10+/lacZ and Sox8lacZ/lacZ,
Sox10+/lacZ embryos varied widely so that there was a
broad phenotypic overlap between these two groups of
embryos. However, the strongest affected animals were
found among the Sox8lacZ/lacZ, Sox10+/lacZ embryos. Similar
results were obtained in whole-mount immunohistochemis-
try, independent of whether enteric crest markers or neuro-
nal markers were used (compare Figs. 5B, E, H, K, N with
C, F, I, L, O).
A detailed quantification was performed on cultures of
acutely dissociated midgut (including caecum) and
hindgut (Figs. 5P, Q). In midgut and caecum, the relative
number of Sox10-positive enteric neural crest cells and of
NOS-positive inhibitory neurons was roughly comparable
between all genotypes with the exception of Sox8lacZ/lacZ,
Sox10+/lacZ embryos (Fig. 5P and data not shown). The
strongly reduced number of enteric crest cells and
neurons in the latter genotype corresponded to the
defective midgut colonization frequently observed for
Sox8lacZ/lacZ, Sox10+/lacZ embryos in whole-mount immu-
nohistochemical analyses (Figs. 5M–O). As a conse-
quence, we also failed to detect enteric neural crest cells
or inhibitory neurons in the hindgut region of these
embryos (Fig. 5Q). Compared to control littermates,
Sox10-positive enteric neural cells and NOS-positive
inhibitory neurons were also reduced in the hindgut
region of Sox8+/lacZ, Sox10+/lacZ embryos (Fig. 5Q).
However, reductions of enteric neural crest cells and
inhibitory neurons were proportionate, thereby confirming
that there is no significant delay in neuronal differ-
entiation in any of the genotypes analyzed.
Even at 16.5 dpc, many guts from Sox8+/lacZ, Sox10+/lacZ
embryos and all analyzed guts of Sox8lacZ/lacZ, Sox10+/lacZ
embryos still exhibited clear defects in colonization by
enteric crest cells as judged by X-gal staining (Figs. 6A–D).
From comparing embryonic phenotypes at 14.5 and 16.5
dpc, it appeared that the wavefront of migrating entericneural crest cells had not significantly advanced. Migration
of these cells had at least not proceeded at any faster rate
than longitudinal growth of the gut. Quantification of cells
in acutely dissociated gut cultures showed absence of ENS
cells for Sox8lacZ/lacZ, Sox10+/lacZ embryos in the distal
ileum and beyond as well as strong reduction of ENS cells
for most Sox8+/lacZ, Sox10+/lacZ embryos in the distal colon
(Fig. 6E). At this age, we also analyzed the percentage of
ENS cells that were already specified to a glial fate by
determining the fraction of Sox10-positive cells co-labeled
by the early glial marker B-FABP (Fig. 6F). Interestingly,
we found a significant reduction of double-positive cells in
Sox8+/lacZ, Sox10+/lacZ embryos indicating that determina-
tion of enteric neural crest cells to a glial fate is decreased in
mice with combined mutations in Sox8 and Sox10. This
decrease was not only observed in the distal colon in which
overall ENS cell numbers were reduced, but also in the
distal ileum in which ENS cell numbers appeared relatively
normal in Sox8+/lacZ, Sox10+/lacZ mice. Therefore, reduced
gliogenesis in mutant mice is not just a consequence of a
reduced cell density in the ENS.
Increased apoptosis of vagal neural crest cells is a major
determinant of the ENS defects in mice with combined Sox8
and Sox10 mutations
To determine the cause of the ENS defect in mice
with combined Sox8 and Sox10 mutations, we also
analyzed proliferation rates of enteric neural crest cells
across the various genotypes (Figs. 7A, B). For this
purpose, we prepared dissociated gut cultures from BrdU-
labeled embryos and identified proliferating enteric neural
crest cells as those cells, which were co-labeled with both
anti-Sox10 and anti-BrdU antibodies. In general, prolif-
eration rates of enteric neural crest cells were higher in
more distal regions where active colonization of the gut
was still ongoing. For instance, 24% of all enteric neural
crest were BrdU-labeled at 12.5 dpc in the stomach of
wildtype embryos and littermates with Sox8 deletions,
whereas 59% were BrdU-labeled in the midgut region
(Fig. 7A). The fraction of BrdU-labeled enteric neural
crest cells had dropped to 33% in the distal midgut of
wildtype embryos and littermates with Sox8 deletions at
16.5 dpc (Fig. 7B). Similarly decreasing rates were also
observed for the hindgut. When proliferation was analyzed
in Sox8lacZ/lacZ, Sox10+/lacZ embryos and Sox8+/lacZ,
Sox10+/lacZ embryos, very similar rates were detected with
one exception. In Sox8+/lacZ, Sox10+/lacZ embryos, there
even was an increase in the percentage of BrdU-labeled
enteric neural crest cells at 16.5 dpc in the colon, which in
contrast to control embryos was not yet fully colonized
(Fig. 7B). Clearly, proliferation rates of enteric neural crest
cells in mice with combined Sox8 and Sox10 deletions
were not lower than those in the wildtype. Compared to the
wildtype, we also failed to detect significant increases in
the number of TUNEL-positive cells in Sox8lacZ/lacZ,
Fig. 5. ENS development in mice with mutant Sox8 and Sox10 alleles at 14.5 dpc. (A–L) Whole-mount immunohistochemistry was performed on guts from
Sox8+/lacZ (A–C), Sox10+/lacZ (D–I), Sox8+/lacZ, Sox10+/lacZ (J–L), and Sox8lacZ/lacZ, Sox10+/lacZ (M–O) embryos using antibodies against h-galactosidase (A,
B, D, E, G, H, J, K, M, N) or neuronal markers PGP9.5 and NOS (C, F, I, L, O). (B, E, H, K, N), magnifications of the respective boxed areas in (A, D, G, J,
M). (P, Q) Fraction of Sox10-positive (filled bars) and NOS-positive (open bars) cells in cultures of acutely dissociated midgut including caecum (P) and
hindgut (Q). On average, approximately 2000 cells were counted for Sox10 and approximately 7000 cells for NOS in four separate cultures from two different
embryos for each genotype. Data are presented as meanF SEM. Differences to the wildtype were statistically significant for Sox8+/lacZ, Sox10+/lacZ embryos in
(Q) and Sox8lacZ/lacZ, Sox10+/lacZ embryos in (P, Q) as determined by the Student’s t test (P V 0.01).
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Fig. 6. ENS development in mice with mutant Sox8 and Sox10 alleles at 16.5
dpc. (A–L) Whole-mount X-Gal staining was performed at 16.5 dpc on guts
from Sox8+/lacZ, Sox10+/lacZ (A, B) and Sox8lacZ/lacZ, Sox10+/lacZ (C, D)
embryos. (B, D)Magnifications of the distalmost colonized areas (marked by
arrows in A, C). (E) Percentage of Sox10-positive cells in cultures of acutely
dissociated distal ileum (filled bars) and distal colon (open bars). Differences
to the wildtype were statistically significant for Sox8+/lacZ, Sox10+/lacZ
embryos in the colon and for Sox8lacZ/lacZ, Sox10+/lacZ embryos in both
regions as determined by the Student’s t test (P V 0.001). (F) Fraction of
Sox10-positive cells co-labeled by B-FABP in acutely dissociated gut
regions. Differences to the wildtype were statistically significant for
Sox10+/lacZ, Sox8+/lacZ embryos as determined by the Student’s t test (P V
0.001). On average, approximately 4000 cells in four separate cultures
from two different embryos were counted for each genotype.
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dpc onwards in whole-mounts or dissociated gut cultures
(data not shown). Rates of apoptosis were similar for
enteric neural crest cells in the different genotypes.
Therefore, we extended our analysis to earlier times in
embryogenesis. Specifically, we determined the behavior of
vagal neural crest cells around the time of immigration into
the foregut (for analyzed region of the embryo, see Fig.
7C). In wildtype, Sox8+/lacZ and Sox8lacZ/lacZ embryos,
these vagal neural crest cells were readily seen entering the
foregut at 9.5 dpc (Fig. 7D, and data not shown). Very few
TUNEL-positive cells were detected in the stream of these
migrating neural crest cells. In Sox10+/lacZ embryos, the
number of TUNEL-positive neural crest cells was already
higher (Fig. 7E). Interestingly, TUNEL-positive cells were
primarily localized outside the gut arguing that vagal neural
crest cells might be more sensitive to cell death beforeentering the gut than the enteric neural crest cells after
entering.
TUNEL-positive vagal neural crest cells were even
more increased in Sox8lacZ/lacZ, Sox10+/lacZ embryos (Fig.
7F), and reached their maximum in Sox10-deficient
embryos (Fig. 7G). In the latter, apoptosis was so high
that neural crest cells failed to reach and enter the gut.
Thus, the most obvious defect in embryos with combined
Sox8 and Sox10 deletions is a dramatically increased death
rate in the vagal neural crest that leads to a drastic
depletion of the enteric neural crest precursor pool before
immigration into the gut.Discussion
Sox10+/lacZ mice model many features of Hirschsprung
disease
Heterozygous Sox10 mutations lead to aganglionosis of
the colon with incomplete penetrance and significant
phenotypic variability in humans and mice (Herbarth et
al., 1998; Pingault et al., 1998; Southard-Smith et al.,
1998). On the mixed C57Bl/6J:C3HeB/FeJ background
used in this study, approximately 20% of the Sox10+/lacZ
mice developed a megacolon and did not survive weaning.
Their colon proved aganglionic over variable distances.
These similarities to the human condition indicate that
Sox10 dosage effects are comparable in both species.
Incomplete penetrance and variable phenotype furthermore
point to the existence and influence of modifier genes as
determinants of the disease. For that matter, mice with
heterozygous Sox10 mutations also offer a unique tool to
identify such modifiers and explain their mode of action
on a molecular basis. In this report, we have identified
Sox8 as such a modifier gene for Sox10. Whether Sox8 is
identical to the modifier gene responsible for the different
incidence of a megacolon in heterozygous Sox10 mice on
a C57Bl/6J versus C3HeB/FeJ background (Southard-
Smith et al., 1999) is not known.
Sox8 is a modifier gene for Sox10-dependent intestinal
aganglionosis
Mice deficient for Sox8 have a reduced weight, but
are viable and fertile (Sock et al., 2001). They do not
show any sign of constipation or megacolon, and there is
no increased early postnatal lethality. By histological and
immunohistochemical criteria, the ENS is normal
throughout the colon. Sox8-related ENS defects appear
only on top of heterozygous Sox10 mutations. The
mortality rate of 77% in Sox8+/lacZ, Sox10+/lacZ mice is
significantly above the approximately 20% observed for
Sox10+/lacZ mice on the same mixed genetic background.
Analysis of the gut of Sox8+/lacZ, Sox10+/lacZ mice
furthermore revealed that the aganglionic segment of
Fig. 7. Proliferation in the developing ENS and apoptosis in the vagal neural crest of mice with mutant Sox8 and Sox10 alleles. (A, B) Fraction of Sox10-
positive cells co-labeled by BrdU in acutely dissociated cultures of stomach (filled bars in A), midgut (open bars in A), ileum (filled bars in B), and colon (open
bars in B) of Sox8+/lacZ, Sox10+/lacZ embryos, Sox8lacZ/lacZ, Sox10+/lacZ embryos and control littermates at 12.5 dpc (A) and 16.5 dpc (B). On average,
approximately 2500 cells in four separate cultures from two different embryos were counted for each genotype. Statistically significant alterations in
proliferation rates relative to the wildtype were detected only in the colon of Sox8+/lacZ, Sox10+/lacZ embryos as determined by the Student’s t test (P V 0.01).
(C–G) Immunohistochemistry was performed on vagal neural crest in post-otic transverse sections of 9.5-dpc-old embryos. Plane and position of section are
indicated in (C). The area shown in (D–G) is marked by a black box. Wildtype (D), Sox10+/lacZ (E), Sox8lacZ/lacZ, Sox10+/lacZ (F), and Sox10lacZ/lacZ embryos
(G) were analyzed using antibodies against Sox10 (D–F) and h-galactosidase (G) (green) in combination with a TUNEL stain (red). The dotted line in (D–G)
demarcates the region of the foregut mesenchyme.
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Sox10+/lacZ mice and often extended beyond the colon far
into the ileum. Thus, loss of Sox8 not only increases
penetrance, but also severity of the disease in Sox10+/lacZ
mice. Arguing for a dosage effect, both parameters of the
ENS defect were even further increased following
inactivation of both Sox8 alleles. During this study,
Sox8lacZ/lacZ, Sox10+/lacZ mice did not survive beyond 8
days of postnatal development. These mice were severelygrowth retarded and exhibited extended aganglionosis in
large and small intestine. Action tremor was also
repeatedly observed due to additional defects in CNS
myelination (Stolt et al., 2004).
Sox8 is co-expressed with Sox10 during ENS development
During embryonic development of the ENS, Sox8 is co-
expressed with Sox10. Both proteins are originally found in
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restricted later to the enteric glial lineage. Sox8 and Sox10
share very high sequence similarities in regions which are
associated with such functions as transcriptional activation,
DNA-binding, and subcellular localization (Kuhlbrodt et al.,
1998a; Pfeifer et al., 2000; Schepers et al., 2000).
Accordingly, biochemical data suggest that Sox8 and
Sox10 have similar DNA binding and subcellular redistrib-
ution properties (Rehberg et al., 2002; Schepers et al., 2003;
Schmidt et al., 2003; Stolt et al., 2004). Sox8 is also capable
of activating Sox10 target genes (Stolt et al., 2004). The
functional similarity between both proteins is further
underscored by the recent finding that overexpression of
Sox8 or Sox10 in the early chick neural tube was equally
efficient in replacing Sox9 in its ability to induce ectopic
neural crest cells (Cheung and Briscoe, 2003).
In general, co-expression causes functionally similar
proteins such as Sox8 and Sox10 to perform redundant
functions and to activate the same genetic programs. Such
functional redundancy between Sox8 and Sox10 readily
explains why loss of each additional Sox8 allele in Sox10
heterozygous mice leads to increasingly stronger ENS
defects. However, it also makes the phenotypic differences
between Sox10+/lacZ and Sox8+/lacZ mice difficult to con-
ceptualize—especially given the fact that Sox8 and Sox10
are expressed at comparable levels from 12.5 to 18.5 dpc in
the developing enteric nervous system. Why should hetero-
zygous loss of Sox10 lead to aganglionosis of the colon and
loss of Sox8 to no phenotype at all?
At the moment, it cannot be excluded that functional
differences between Sox8 and Sox10 proteins so far escaped
cell culture or biochemical studies. The two proteins might
differ in their ability to interact with proteins that differ-
entially modulate transcriptional capacity. Additionally,
Sox8 might be less stable than Sox10 so that protein
amounts for Sox8 are lower than for Sox10 despite similar
expression levels. However, the conspicuous absence of
survival and proliferation defects in enteric neural crest cells
between 12.5 and 16.5 dpc argues for full compensation
between both proteins during this phase of ENS develop-
ment. Therefore, the differential requirement for Sox8 and
Sox10 might not be in the enteric neural crest cells, but
rather before in the vagal crest (see below).
ENS defects in mice with Sox10 and Sox8 deficiencies are
not primarily due to defects in enteric glia
Both Sox10 and Sox8 are not only present during most
phases of ENS development, they are already co-expressed
in vagal neural crest before these cells enter the gut (Kapur,
1999; Sock et al., 2001). Thus, the ENS defect in Sox10
heterozygous mice could in principle be due to defective
development of the vagal neural crest, the enteric neural
crest or the enteric glial cell lineage. Additionally, several
different processes could be affected as Sox10 has been
shown to influence maintenance of pluripotency, survival,proliferation, specification and terminal differentiation
under different conditions (Britsch et al., 2001; Kim et al.,
2003; Paratore et al., 2001; Sonnenberg-Riethmacher et al.,
2001; Stolt et al., 2002).
ENS development was already affected in the mouse
mutants before enteric glia or their precursors appeared in
significant numbers. Thus, it appears unlikely that the
observed ENS phenotype is primarily caused by a glia-
specific defect. This contrasts significantly with the situation
in the sensory part of the peripheral nervous system, where
in the absence of Sox10, glial cells fail to be specified,
before sensory neurons degenerate later on (Britsch et al.,
2001).
We did, however, observe a relative reduction of glial
cells in Sox8+/lacZ, Sox10+/lacZ mice at 16.5 dpc. There were
no B-FABP-positive glial precursors in the most distal
colonized gut region. In the same region, neurogenesis was
largely normal. This finding could be interpreted as a cell-
intrinsic glial specification defect. As glial fate choice in
neural crest cultures is dependent on community effects and
requires a certain cell density (Paratore et al., 2001), glial
specification could also be reduced because of decreased
densities of enteric neural crest cells in this region. In the
latter case, Sox10 and Sox8 mutations would only be
indirectly accountable for the loss of glial cells. Interest-
ingly, however, glial precursors were also reduced in the
distal ileum of Sox8+/lacZ, Sox10+/lacZ mice which contained
normal numbers of enteric neural crest cells at 16.5 dpc.
This latter finding is compatible with a model in which Sox8
and Sox10 influence specification of enteric glia cell-
intrinsically. Whether the observed reduction in enteric glia
is transient or permanent needs to be established in future
studies.
ENS defects in mice with Sox10 and Sox8 deficiencies are
not primarily due to defects in the enteric neural crest
From earliest times onwards, colonization of the gut by
enteric neural crest cells from the vagal region was
significantly retarded in most embryos of a Sox8+/lacZ,
Sox10+/lacZ or a Sox8lacZ/lacZ, Sox10+/lacZ genotype, and in a
minor fraction of Sox10+/lacZ embryos. Our data imply that
the retardation observed at early times of ENS development
is never compensated and might even correlate with the
length of the aganglionic gut segment observed in postnatal
animals. We also found no evidence in our compound
mutants for significant colonization of the colon by neural
crest stemming from the sacral region (Le Douarin and
Kalchheim, 1999) indicating that the sacral crest in
mammals might be similarly unable to replace missing
vagal crest cells during ganglia formation in the colon as the
chick sacral crest (Burns et al., 2000; Hearn and Newgreen,
2000).
Interestingly, even in those embryos where large seg-
ments of the midgut and hindgut remained uncolonized,
colonized regions in moderate distance to the wavefront of
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and neurons in numbers comparable to the wildtype. In
more general terms, this observation might point to the fact
that continued forward migration of enteric neural crest cells
is coupled to a mechanism that counts the density of enteric
neural crest cells in the latest colonized areas so that
migration is only continued once a certain cell density has
been achieved.
If aganglionosis in Sox10 heterozygous mice (with and
without additional loss of Sox8) is caused by defective
colonization, decreased proliferation or increased apoptosis
of enteric neural crest cells might be responsible.
Surprisingly, we did not find evidence for either model.
Similar to endothelin receptor B (Shin et al., 1999), Sox10
might therefore not be essential for ENS development
after 12.5 dpc.
Currently, we do not know whether loss of Sox10 and
Sox8 alleles directly affects migration of enteric neural
crest cells. However, we did not observe increased
densities of enteric neural crest cells in the region closely
behind the migratory wavefront in Sox8+/lacZ, Sox10+/lacZ
or Sox8lacZ/lacZ, Sox10+/lacZ embryos. Also, migration was
not halted at any defined region along the gut such as the
caecum where changes of the gut environment impose
particular strains on the migrating enteric neural crest cells.
Still, migration is at least retarded so strongly that colon
growth exceeds the migratory ability of the enteric crest
cells in most Sox8+/lacZ, Sox10+/lacZ and Sox8lacZ/lacZ,
Sox10+/lacZ embryos until the colon is no longer permis-
sive for colonization.
ENS defects in mice with Sox10 and Sox8 deficiencies are
due to defects in the vagal neural crest
Early studies in the chick already showed that partial
ablation of the vagal crest led to a Hirschsprung-like
aganglionosis of the colon (Yntema and Hammond, 1954).
Therefore, the ENS defect in Sox8+/lacZ, Sox10+/lacZ and
Sox8lacZ/lacZ, Sox10+/lacZ embryos could also be caused by an
already decreased number of vagal crest cells. Analysis of
these vagal neural crest cells at the time when they entered the
gut revealed a strongly increased apoptosis in Sox10+/lacZ
mice and an even higher rate in Sox8lacZ/lacZ, Sox10+/lacZ
mice. Rates of apoptosis were always significantly higher
outside the gut, arguing that neural crest cells were much less
susceptible to loss of Sox10 and Sox8 alleles once they had
entered the gut. Previous studies had already shown that the
vagal neural crest was affected much stronger by homozy-
gous Sox10 mutations than the trunk neural crest and that
complete aganglionosis in Sox10dom/dom embryos resulted
from dramatic cell death in the vagal neural crest population
(Herbarth et al., 1998; Kapur, 1999; Southard-Smith et al.,
1998). We show here that cell death is indeed so high in
embryos with homozygous Sox10 mutation that in contrast
to Sox10+/lacZ or Sox8lacZ/lacZ, Sox10+/lacZ mice, vagal
neural crest cells did not even reach and enter the gut.Our results favor a model in which the most important cause
for the observed ENS defect is a reduced survival of vagal
neural crest cells before they enter the gut, placing the ENS
defect in our mice before 10 dpc and thus before the ENS
defect in mice deficient for the endothelin receptor B (Shin
et al., 1999). This, of course, does not rule out that Sox8 and
Sox10 have additional consecutive roles in ENS develop-
ment which might be less sensitive to dosage effects or
masked by near complete redundancy between Sox8 and
Sox10 at later times.
The phenotype of mice with combined Sox8 and Sox10
mutations must therefore be explained by the relationship of
these two proteins in the vagal neural crest. Despite the
increased rate of apoptosis in the Sox10+/lacZ neural crest,
we detected 3-fold higher expression levels for Sox10 than
for the functionally redundant Sox8. Differential contribu-
tion to a common function in the vagal neural crest through
such differences in amount could easily explain why
heterozygous mutations of the major player Sox10, but
not Sox8 as a minor contributor lead to gut aganglionosis
and why Sox8 mutations invariably increase the severity of
Sox10 mutations. Similar explanations have been invoked
to explain oligodendrocyte and Sertoli cell phenotype in
mice with combined Sox E gene mutations (Chaboissier et
al., 2004; Stolt et al., 2004). We propose that such unequal
contributions of related proteins to an essential function
could be a common mode of action for genetic modifiers.
Whereas ENS defects in mice with Sox10 and Sox8
deficiencies are likely caused by a depletion of vagal neural
crest before 10 dpc, defects observed upon inactivation of
the endothelin-3 signaling pathway rather affect prolifer-
ation and migration of enteric crest cells between 10 and
12.5 dpc (Barlow et al., 2003; Kruger et al., 2003; Shin et
al., 1999). Thus, despite similar phenotypic endpoints, the
underlying cause of the ENS defect, the affected cell type,
and the timing are different in Sox10-based and endothelin/
endothelin receptor-based mouse models of Hirschsprung
disease. Any attempt at treatment of human Hirschsprung
disease would have to take this existence of multiple
molecular ontogenies into account and determine the exact
genetic cause first.Acknowledgments
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